Table 1.
Dog Description, Including Medication Use
| Dog | Breed | Sex | Eye(s) Affected | Age (Years) | Treatment BF MSC Immunosuppressive Drugs | Treatment With AT |
|---|---|---|---|---|---|---|
| 1 | Shitzu | M | L | 3 | No | Yes |
| 2 | Mongrel | F | R | 4 | No | No |
| 3 | Great Dane | F | R | 8 | No | No |
| 4 | Bulldog | F | R and L | 4 | No | Yes |
| 5 | Ihasa Apso | M | R and L | 11 | Tacrolimus | No |
| 6 | Poodle | F | R and L | 6 | Tacrolimus | Yes |
| 7 | Cocker | M | R and L | 10 | No | No |
| 8 | ShihTzu | F | R | 3 | No | No |
| 9 | Beagle | M | R | 5 | Tacrolimus | Yes |
| 10 | Pit Bull | F | R | 11 | Ciclosporine | Yes |
| 11 | Ihasa Apso | F | R and L | 9 | Tacrolimus | No |
| 12 | Lhasa | F | R and L | 5 | Tacrolimus | No |
| 13 | Cocker | F | R and L | 12 | Tacrolimus | No |
| 14 | Lhasa | F | R and L | 8 | Tacrolimus | No |
| 15 | Golden Retriever | F | R and L | 9 | Tacrolimus | Yes |
Artificial treatment (0.2% sodium hyaluronate) was allowed to continue throughout the study. Use of immunosuppresants was discontinued 1 month before transplantation and throughout the study. R, right eye; L, left eye; BF, before; AT, artificial tears; F, female; M, male.